Predictors of cardiac hepatopathy in patients with right heart failure

Sherry Megalla1, Dvorah Holtzman, Wilbert S Aronow

  • 1Department of Medicine, Cardiology Division, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.

Insights

Cardiac hepatopathy (CH) in right heart failure patients is linked to elevated right ventricular diastolic pressure, suggesting congestion. In some cases without left heart failure, low cardiac output also contributes to CH.

Area of Science:

  • Cardiology
  • Hepatology
  • Pulmonology

Background:

  • Cardiac hepatopathy (CH) is a complication in some patients with right heart failure.
  • Its development is attributed to hepatic venous congestion and arterial ischemia.
  • Understanding CH's characteristics is crucial for managing right heart failure.

Purpose of the Study:

  • To define the clinical and hemodynamic characteristics associated with cardiac hepatopathy.
  • To identify factors contributing to the development of CH in patients with right heart dysfunction.

Main Methods:

  • Retrospective cross-sectional analysis of 188 patients.
  • Inclusion criteria: echocardiography showing right ventricular (RV) hypokinesis or dilatation within 30 days of right heart catheterization.
  • Exclusion of non-cardiac causes of hepatopathy; chart review for clinical data.

Main Results:

  • Etiologies for right heart dysfunction included left heart failure, shunt, pulmonary hypertension, and valvular disease.
  • Higher RV diastolic pressure and RV dysfunction not due to left heart failure were associated with CH.
  • Low cardiac output was linked to CH only in patients without left heart failure.

Conclusions:

  • Elevated RV diastolic pressure is the primary factor in CH, indicating congestion.
  • Low cardiac output may contribute to CH pathophysiology in specific patient groups without left heart failure.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...